Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Hepatoblastoma 1

Interventions

Vincristine 2Specimen Handling 2Gene Expression Profiling 2Fluorouracil 2Cisplatin 2Carboplatin 2sodium thiosulfate 1imetelstat 1dehydroftorafur 1X-Rays 1Watchful Waiting 1Sorafenib 1Restraint, Physical 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Phantoms, Imaging 1Oxaliplatin 1Observation 1Microarray Analysis 1MLN 8237 1Irinotecan 1Gene Rearrangement 1Gemcitabine 1GRN163L peptide 1Etoposide 1Doxorubicin 1Cytogenetic Analysis 1Bone Density 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hepatoblastoma × MLN 8237 × Clear all
NCT01154816 2020-05-13

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Children's Oncology Group

Phase 2 Completed
118 enrolled 24 charts
CNSGastrointestinalLymphoidOther hematologic neoplasmSarcoma

Neuroblastoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡